Recce Pharmaceuticals Establishes Strategic Partnership in S

Memorandum of Understanding (MoU) with leading Indonesian biomedical company PT Etana BiotechnologiesMoU aims to facilitate late-stage clinical trials in Indonesia, supporting the Indonesian Government’s access to novel infectious disease medicinesOpportunity to access 10 ASEAN member states1 covering a population of 670 million inhabitantsPatient populations readily available focused on significant unmet medical needs particular to the regionSignificant bilateral initiative supported by the Aus

Related Keywords

United States , Australia , Sydney , New South Wales , Indonesia , Australian , Indonesian , James Graham , Laksana Tri Handoko , Michael Fitzhugh , Andrew Geddes , Budi Sadikin , Guillame Van Renterghem , Head Of The National Research , Recce Pharmaceuticals Ltd , Lifesci Communications , Innovation Agency , Indonesian Ulema Council , Recce Pharmaceuticals , Indonesian Government , Pharmaceuticals Ltd , Indonesian Minister , Senior Executives , Her Excellency Penny Williams , Australian Ambassador , National Research , Tri Handoko , Chief Executive Officer , Bilateral Collaboration , Asia Pacific , Southeast Asian , New Class , Synthetic Anti Infectives , Infectious Disease Product , Generating Antibiotic Initiatives Now , Fast Track Designation , Pew Charitable Trusts Global New Antibiotics , Development Pipeline , Investor Relations , Infectious Disease , Antimicrobial Resistance , Global Health , Ndonesian Minister Of Health , Pharmaceuticals , Lecce ,